Skip to main content
Top
Published in:

Open Access 13-11-2024 | Endogenous Cushing's Syndrome | Case Report

Ectopic adrenocorticotrophic hormone syndrome in a 10-year-old girl with a thymic neuroendocrine tumor: a case report

Authors: Irena Aldhoon-Hainerová, Mikuláš Kosák, Michal Kršek, David Zogala, Karel Pacak

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Background

Thymic neuroendocrine tumor as a cause of Cushing syndrome is extremely rare in children.

Case presentation

We report a case of a 10-year-old girl who presented with typical symptoms and signs of hypercortisolemia, including bone fractures, growth retardation, and kidney stones. The patient was managed with oral ketoconazole, during which she experienced adrenal insufficiency, possibly due to either cyclic adrenocorticotropic hormone (ACTH) secretion or concurrent COVID-19 infection. The patient underwent a diagnostic work-up which indicated the possibility of an ACTH-secreting pituitary neuroendocrine tumor. However, after a transsphenoidal surgery, the diagnosis was not confirmed on histopathological examination. Subsequent bilateral inferior petrosal sinus sampling showed strong indications of the presence of ectopic ACTH syndrome. Detailed rereading of functional imaging studies, including 18F-FDG PET/MRI and 68Ga DOTATOC PET/CT, ultimately identified a small lesion in the thymus. The patient underwent videothoracoscopic thymectomy that confirmed a neuroendocrine tumor with ACTH positivity on histopathological examination.

Conclusion

This case presents some unique challenges related to the diagnosis, management, and treatment of thymic neuroendocrine tumor in a child. We can conclude that ketoconazole treatment was effective in managing hypercortisolemia in our patient. Further, a combination of functional imaging studies can be a useful tool in locating the source of ectopic ACTH secretion. Lastly, in cases of discrepancy in the results of stimulation tests, bilateral inferior petrosal sinus sampling is highly recommended to differentiate between Cushing disease and ectopic ACTH syndrome.
Literature
1.
go back to reference Streuli R. A rare case of an ACTH/CRH co-secreting midgut neuroendocrine tumor mimicking Cushing’s disease. Endocrinol Diabetes Metab Case Rep. 2017;2017:17–58. ,Krull I, Brändle M, et al.PubMedPubMedCentral Streuli R. A rare case of an ACTH/CRH co-secreting midgut neuroendocrine tumor mimicking Cushing’s disease. Endocrinol Diabetes Metab Case Rep. 2017;2017:17–58. ,Krull I, Brändle M, et al.PubMedPubMedCentral
2.
go back to reference Karageorgiadis AS, Papadakis GZ, Biro J, et al. Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab. 2015;100(1):141–8.CrossRefPubMed Karageorgiadis AS, Papadakis GZ, Biro J, et al. Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab. 2015;100(1):141–8.CrossRefPubMed
3.
go back to reference Castinetti F, Guignat L, Giraud P, et al. Ketoconazole in Cushing’s disease: is it worth a try? J Clin Endocrinol Metab. 2014;99(5):1623–30.CrossRefPubMed Castinetti F, Guignat L, Giraud P, et al. Ketoconazole in Cushing’s disease: is it worth a try? J Clin Endocrinol Metab. 2014;99(5):1623–30.CrossRefPubMed
4.
go back to reference Mi Q, Yin M-Z, Gao Y-J et al. Thymic atypical carcinoid with cyclical Cushing’s syndrome in a 7-year-old boy: a case report and review of the literature. Intern Med. 2014;4(5). Mi Q, Yin M-Z, Gao Y-J et al. Thymic atypical carcinoid with cyclical Cushing’s syndrome in a 7-year-old boy: a case report and review of the literature. Intern Med. 2014;4(5).
5.
go back to reference Moszczyńska E, Pasternak-Pietrzak K, Prokop-Piotrkowska M, et al. Ectopic ACTH production by thymic and appendiceal neuroendocrine tumors - two case reports. J Pediatr Endocrinol Metab. 2020;34(1):141–6.CrossRefPubMed Moszczyńska E, Pasternak-Pietrzak K, Prokop-Piotrkowska M, et al. Ectopic ACTH production by thymic and appendiceal neuroendocrine tumors - two case reports. J Pediatr Endocrinol Metab. 2020;34(1):141–6.CrossRefPubMed
6.
go back to reference Crock PA, Ludecke DK, Knappe UJ, et al. A personal series of 100 children operated for Cushing’s disease (CD): optimizing minimally invasive diagnosis and transnasal surgery to achieve nearly 100% remission including reoperations. J Pediatr Endocrinol Metab. 2018;31(9):1023–31.CrossRefPubMed Crock PA, Ludecke DK, Knappe UJ, et al. A personal series of 100 children operated for Cushing’s disease (CD): optimizing minimally invasive diagnosis and transnasal surgery to achieve nearly 100% remission including reoperations. J Pediatr Endocrinol Metab. 2018;31(9):1023–31.CrossRefPubMed
7.
go back to reference Elenius H, McGlotten R, Nieman LK. Ovine CRH stimulation and 8 mg dexamethasone suppression tests in 323 patients with ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab. 2023;109(1):e189–189.CrossRef Elenius H, McGlotten R, Nieman LK. Ovine CRH stimulation and 8 mg dexamethasone suppression tests in 323 patients with ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab. 2023;109(1):e189–189.CrossRef
8.
go back to reference Detomas M, Ritzel K, Nasi-Kordhishti I, et al. Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing’s syndrome. Front Endocrinol (Lausanne). 2022;13:955945.CrossRefPubMed Detomas M, Ritzel K, Nasi-Kordhishti I, et al. Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing’s syndrome. Front Endocrinol (Lausanne). 2022;13:955945.CrossRefPubMed
9.
go back to reference Yogi-Morren D, Habra MA, Faiman C, et al. Pituitary MRI findings in patients with pituitary and ectopic ACTH-dependent Cushing syndrome: does a 6-mm pituitary tumor size cut-off value exclude ectopic ACTH syndrome? Endocr Pract. 2015;21(10):1098–103.CrossRefPubMed Yogi-Morren D, Habra MA, Faiman C, et al. Pituitary MRI findings in patients with pituitary and ectopic ACTH-dependent Cushing syndrome: does a 6-mm pituitary tumor size cut-off value exclude ectopic ACTH syndrome? Endocr Pract. 2015;21(10):1098–103.CrossRefPubMed
10.
go back to reference Albani A, Berr CM, Beuschlein F, et al. A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing’s syndrome. BMC Endocr Disord. 2019;19(1):105.CrossRefPubMedPubMedCentral Albani A, Berr CM, Beuschlein F, et al. A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing’s syndrome. BMC Endocr Disord. 2019;19(1):105.CrossRefPubMedPubMedCentral
11.
go back to reference Tan H, Chen D, Yu Y, et al. Unusual ectopic ACTH syndrome in a patient with orbital neuroendocrine tumor, resulted false-positive outcome of BIPSS: a case report. BMC Endocr Disord. 2020;20(1):116.CrossRefPubMedPubMedCentral Tan H, Chen D, Yu Y, et al. Unusual ectopic ACTH syndrome in a patient with orbital neuroendocrine tumor, resulted false-positive outcome of BIPSS: a case report. BMC Endocr Disord. 2020;20(1):116.CrossRefPubMedPubMedCentral
12.
go back to reference Ahmed MF, Ahmed S, Abdussalam A, et al. A rare case of ectopic adrenocorticotropic hormone syndrome (EAS) in an adolescent girl with a thymic neuroendocrine tumour. Cureus. 2024;16(8):e66615.PubMedPubMedCentral Ahmed MF, Ahmed S, Abdussalam A, et al. A rare case of ectopic adrenocorticotropic hormone syndrome (EAS) in an adolescent girl with a thymic neuroendocrine tumour. Cureus. 2024;16(8):e66615.PubMedPubMedCentral
13.
go back to reference Hanson JA, Sohaib SA, Newell-Price J, et al. Computed tomography appearance of the thymus and anterior mediastinum in active Cushing’s syndrome. J Clin Endocrinol Metab. 1999;84:602–5.PubMed Hanson JA, Sohaib SA, Newell-Price J, et al. Computed tomography appearance of the thymus and anterior mediastinum in active Cushing’s syndrome. J Clin Endocrinol Metab. 1999;84:602–5.PubMed
14.
go back to reference Wannachalee T, Turcu AF, Bancos I, et al. The clinical impact of [68 Ga]-DOTATATE PET/CT for the diagnosis and management of ectopic adrenocorticotropic hormone - secreting Tumours. Clin Endocrinol (Oxf). 2019;91(2):288–94.CrossRefPubMed Wannachalee T, Turcu AF, Bancos I, et al. The clinical impact of [68 Ga]-DOTATATE PET/CT for the diagnosis and management of ectopic adrenocorticotropic hormone - secreting Tumours. Clin Endocrinol (Oxf). 2019;91(2):288–94.CrossRefPubMed
15.
go back to reference Liu Q, Zang J, Yang Y, et al. Head-to-head comparison of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in localizing tumors with ectopic adrenocorticotropic hormone secretion: a prospective study. Eur J Nucl Med Mol Imaging. 2021;48(13):4386–95.CrossRefPubMed Liu Q, Zang J, Yang Y, et al. Head-to-head comparison of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in localizing tumors with ectopic adrenocorticotropic hormone secretion: a prospective study. Eur J Nucl Med Mol Imaging. 2021;48(13):4386–95.CrossRefPubMed
16.
go back to reference Flesiriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9(12):847–75.CrossRef Flesiriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9(12):847–75.CrossRef
Metadata
Title
Ectopic adrenocorticotrophic hormone syndrome in a 10-year-old girl with a thymic neuroendocrine tumor: a case report
Authors
Irena Aldhoon-Hainerová
Mikuláš Kosák
Michal Kršek
David Zogala
Karel Pacak
Publication date
13-11-2024
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01756-5

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more